1R. Leo,M. Boeker,D. Peest,R. Hein,R. Bartl,J. E. Gessner,J. Seibach,G. Wacker,H. Deicher. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells[J] 1992,Annals of Hematology(3):132～139
7Jooeun Bae,Nikhil C,Munshi,et al.Immunotherapy Strategies in Multiple Myeloma.Hematology/Oncology Clinics of North America,2014,28(5):927-943.
8Stevenson JD,Wall C,Patel A,et al.Multiple myeloma:a review.Orthopaedics and Trauma,2014,28(3):187-193.
9Tomer M.Coleman M&M,Ruben Niesvizky.Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.leukemia Research,2014,38(5):517-524.
10Foreman AL,Van de Water J,Gougeon ML,et al.B cells in autoimmune diseases:insights from analyses of immunoglobulin variable(Ig V)gene usage.Autoimmune Rev,2007,6(6):387-401.
